LifeAssays
2000
FOUNDED
PUBLIC
STATUS
11-20
EMPLOYEES
LIFE B
STOCK SYMBOL
1
INVESTMENTS
$0.17
SHARE PRICE
(As of Friday Closing)
Description
Lifeassays is a Swedish diagnostic company focused on providing point-of-care diagnostic testing for community health centres, primary physicians and veterinarians based on a unique patented point-of-care technology platform. The company offers Equine health, Cannie health, and Feline health test. Its products include feline serum amyloid A starkit, equine SAA kit, Canine CCRP kit, and others.
Primary Industry
Diagnostic Equipment
Stock Exchange
NGM
Primary Office
- Sölvegatan 43 A
- 223 70 Lund
- Sweden
+46 046-286 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore LifeAssays’s full profile, request a free trial.
LifeAssays Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.11 - $1.11 | $1.34M | $0.12 | -$0.47 | 17.3K | 9.2M |
LifeAssays Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
FY 2015
31-Dec-2015
|
|---|---|---|---|---|
| Enterprise Value | 3,146 | 3,920 | 8,714 | 1,512 |
| Revenue | 676 | 776 | 870 | 567 |
| EBITDA | (2,469) | (2,225) | (1,983) | (1,992) |
| Net Income | (2,726) | (2,482) | (2,221) | (2,073) |
| Total Assets | 4,173 | 4,461 | 3,614 | 3,284 |
| Total Debt | 1,353 | 1,386 | 1,072 | 1,018 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
LifeAssays Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000000 0000000 | 07-Nov-2015 | 000000000000000000 | 00000 | Other Healthcare Technology Systems | 000000 0000000 |
LifeAssays Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 0000000000 0000000 | Other Healthcare Technology Systems | Vantaa, Finland |
LifeAssays Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Dan Wahrenberg | Chief Financial Officer | ||
| Anders Norling | Chairman |